Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in BIOCRYST PHARMACEUTICALS INC
CAPITAL FUND MANAGEMENT S.A. holds 57,138 shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $543,953 as of 2026-Q1. This is a new position. BCRX represents 0.0% of CAPITAL FUND MANAGEMENT S.A.'s portfolio.
Current Value
$543,953
Current Shares
57,138
Total Value Change
-$985,844
Total Shares Change
-190,402
Other major holders of BCRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
New |
| 57,138 |
- |
| $543,953 |
| 0.0% |
| $8.69 |
34 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $7.55 | 0 |
| 2025-Q2 | New | 51,913 | - | $465,140 | 0.0% | $9.36 | 33 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $7.86 | 0 |
| 2024-Q4 | Decreased | 59,327 | -83.4% | $446,139 | 0.0% | $7.53 | 0 |
| 2024-Q3 | Increased | 357,615 | +44.5% | $2.7M | 0.0% | $7.62 | 36 |
| 2024-Q2 | Increased | 247,540 | +17.0% | $1.5M | 0.0% | $6.18 | 30 |